<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.35074.010</object-id><label>Table 1.</label><caption><title>Nur77-eGFP is a specific reporter of antigen-dependent signaling in vivo.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Conclusion</th><th valign="bottom">Stimulus/perturbation</th><th valign="bottom">Pathway</th><th valign="bottom">Readout</th><th valign="bottom">Cell type</th><th valign="bottom">References</th></tr></thead><tbody><tr><td rowspan="6">Does not modulate Nur77 at steady state in vivo</td><td><italic>CD40L<sup>-/-</sup></italic></td><td>CD40</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1A</xref></td></tr><tr><td><italic>TLR7<sup>-/-</sup></italic></td><td>TLR7</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1A</xref></td></tr><tr><td><italic>Un93b1<sup>3d/3d</sup></italic></td><td>TLR3/7/9</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1A</xref></td></tr><tr><td><italic>MyD88<sup>fl/fl</sup></italic> MB1-Cre</td><td>MyD88</td><td>Endog. Nur77 protein/transcript</td><td>PerC B1a cells/spleen</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1F,G</xref></td></tr><tr><td>Germ-free mice</td><td>MyD88/TRIF</td><td>Endog. Nur77 protein/transcript</td><td>Splenic B cells/spleen</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1D,E</xref></td></tr><tr><td>Const. act. STAT5</td><td>Jak/Stat</td><td>Nur77-eGFP</td><td>Thymocytes</td><td>Moran et al. JEM 2011, Figure 8.</td></tr><tr><td rowspan="4">Does not induce Nur77 in vitro</td><td>BAFF</td><td>BAFFR</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>: Figure S1G</td></tr><tr><td>IL-4</td><td>Jak/Stat</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1B</xref></td></tr><tr><td>IL-2, IL-15</td><td>Jak/Stat</td><td>Nur77-eGFP</td><td>CD8 (IL-2, 15), CD4 (IL-2)</td><td>Au-Yeung et al. JI 2017, Figures S1A, 3C, 4A</td></tr><tr><td>CXCL12/ <break/>SDF-1</td><td>CXCR4</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1C</xref></td></tr><tr><td rowspan="4">Induces Nur77 in vitro but does not require IgM or IgD specifically</td><td>LPS</td><td>TLR4, Rp150</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>: Figure S1G; Manuscript <xref ref-type="fig" rid="fig1s3">Figure 1&#8212;figure supplement 3A</xref></td></tr><tr><td>CpG</td><td>TLR9</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>, Figure S1G; Manuscript <xref ref-type="fig" rid="fig1s3">Figure 1&#8212;figure supplement 3A</xref></td></tr><tr><td>Pam3CSK4</td><td>TLR1/2</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig1s3">Figure 1&#8212;figure supplement 3A</xref></td></tr><tr><td>Anti-Ig&#954;</td><td>BCR</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig2">Figure 2F</xref></td></tr><tr><td rowspan="4">Modulates pathway at steady state in vivo</td><td>IgHEL Tg</td><td>Antigen/BCR</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>, <xref ref-type="fig" rid="fig3">Figure 3B,C</xref>; Manuscript <xref ref-type="fig" rid="fig1">Figure 1A</xref></td></tr><tr><td>IgHEL BCR Tg/sHEL Ag</td><td>Antigen/BCR</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>,&#160;Figure&#160;3B,C; Manuscript <xref ref-type="fig" rid="fig1">Figure 1A</xref></td></tr><tr><td><italic>Lyn<sup>-/-</sup></italic></td><td>BCR via ITIMs</td><td>Nur77-eGFP</td><td>B cells</td><td>Manuscript <xref ref-type="fig" rid="fig5s3">Figure 5&#8212;figure supplement 3A</xref></td></tr><tr><td>CD45 allelic series</td><td>BCR via SFKs</td><td>Nur77-eGFP</td><td>B cells</td><td><xref ref-type="bibr" rid="bib78">Zikherman et al. (2012)</xref>,&#160;Figure&#160;3A,B</td></tr></tbody></table></table-wrap>